1-3 of 3
Marc Lopez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B128: Preclinical characterization of ETx-22, a next-generation antibody drug conjugate (ADC) targeting nectin-4

Free
Hatem Azim, Florence Lhospice, Xavier Preville, Joanna Fares, Marc Lopez, Emerence Crompot, Emmanuelle Josselin, Remy Castellano, Maria Wehbeh, Yves Collette, Jack Elands, Daniel Olive
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12_Supplement): B128.
https://doi.org/10.1158/1535-7163.TARG-23-B128
Published: 01 December 2023
View articletitled, Abstract B128: Preclinical characterization of ETx-22, a next-generation antibody drug conjugate (ADC) targeting nectin-4
Journal Articles

First-in-Human, Phase I Study of PCA062 in Solid Tumors—Letter

Available to Purchase
Bernadette de Rauglaudre, Pascal Finetti, David Jérémie Birnbaum, Marc Lopez, François Bertucci, Emilie Mamessier
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (11): 1742–1743.
https://doi.org/10.1158/1535-7163.MCT-22-0240
Published: 03 November 2022
View articletitled, First-in-Human, Phase I Study of PCA062 in Solid Tumors—Letter
Open the PDF for First-in-Human, Phase I Study of PCA062 in Solid Tumors—Letter in another window
Journal Articles

Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate

Available to Purchase
Olivier Cabaud, Ludovic Berger, Emerence Crompot, José Adélaide, Pascal Finetti, Sèverine Garnier, Arnaud Guille, Nadine Carbuccia, Anne Farina, Emilie Agavnian, Max Chaffanet, Anthony Gonçalves, Emmanuelle Charafe-Jauffret, Emilie Mamessier, Daniel Birnbaum, François Bertucci, Marc Lopez
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (7): 1227–1235.
https://doi.org/10.1158/1535-7163.MCT-22-0013
Published: 05 July 2022
View articletitled, Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate
Open the PDF for Overcoming Resistance to Anti–Nectin-4 Antibody-Drug Conjugate in another window
Includes: Supplementary data